Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CLL1: Fludarabine vs Observation in Early Stage CLL
NCT00262782Phase 3Completed
- Sponsor
- German CLL Study Group
- Start
- Apr 1997
- Primary completion
- Dec 2004
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 2
01
Overview
Phase 3, randomised, open-label trial of fludarabine in chronic lymphocytic leukemia (CLL) (2 arms), sponsored by German CLL Study Group. Primary endpoint: Progression-Free Survival. Started Apr 1997; status: completed.
02
Drugs
fludarabine
03
Conditions
chronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00262782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262782.